HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ECHA Looks Ahead To 2018 REACH Deadline With Draft Five-Year Plan

This article was originally published in The Rose Sheet

Executive Summary

The European Chemicals Agency has four key objectives under its draft five-year plan, including “maximizing the availability of high-quality information” under European Registration, Evaluation, Authorization and Restriction of Chemicals law. Released May 28, the plan is the first of its kind, outlining the agency’s goals leading up to the final REACH deadline in 2018.

You may also be interested in...



ECHA Provides Cues For Self-Assessing REACH Deadline Preparedness

As the May 31 REACH deadline approaches, dossier registrants should know their roles within SIEF registrant groups and ensure that dossiers clearly identify and characterize substances, says the European Chemicals Agency. Over 3,000 substances are expected to have been registered by June.

ECHA Should Commit To SVHC Substitution, Not SVHC Manufacturers – EEB

Speakers at ECHA’s eighth annual Stakeholders Day in Helsinki, representing the European Environmental Bureau and ECHA’s Risk Management Implementation division, address ECHA’s environmental and public-safety responsibilities and the risks involved in seeking authorization for substances of very high concern under European REACH law, respectively.

REACH Progress Report Cites Familiar Problems, With Some Improvement

ECHA sees some improvement in REACH dossiers, but familiar problems remain, according to its 2012 Progress Report. The agency notes that 2012 was a “crucial” year as it completed its examination of all testing proposals received for the first REACH deadline in 2010.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018557

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel